These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18497530)

  • 21. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.
    Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H
    Retina; 2009; 29(7):960-5. PubMed ID: 19491727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator.
    Singh RP; Patel C; Sears JE
    Br J Ophthalmol; 2006 Apr; 90(4):429-31. PubMed ID: 16547320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy.
    Kuhli-Hattenbach C; Fischer IB; Schalnus R; Hattenbach LO
    Am J Ophthalmol; 2010 Feb; 149(2):316-321.e1. PubMed ID: 19939348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Parravano M; Oddone F; Tedeschi M; Schiano Lomoriello D; Chiaravalloti A; Ripandelli G; Varano M
    Retina; 2009 Mar; 29(3):329-34. PubMed ID: 19092732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Little effect of tissue plasminogen activator in subretinal surgery for acute hemorrhage in age-related macular degeneration.
    Hesse L; Meitinger D; Schmidt J
    Ger J Ophthalmol; 1996 Nov; 5(6):479-83. PubMed ID: 9479539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reading performance with low-vision aids and vision-related quality of life after macular translocation surgery in patients with age-related macular degeneration.
    Nguyen NX; Besch D; Bartz-Schmidt K; Gelisken F; Trauzettel-Klosinski S
    Acta Ophthalmol Scand; 2007 Dec; 85(8):877-82. PubMed ID: 17651462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator.
    Yang PM; Kuo HK; Kao ML; Chen YJ; Tsai HH
    Chang Gung Med J; 2005 Dec; 28(12):852-9. PubMed ID: 16515019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH; Wu TT; Hong MC; Sheu SJ
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of cataract surgery on quality of life in patients with early age-related macular degeneration.
    Lamoureux EL; Hooper CY; Lim L; Pallant JF; Hunt N; Keeffe JE; Guymer RH
    Optom Vis Sci; 2007 Aug; 84(8):683-8. PubMed ID: 17700333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitreous hemorrhage complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Wu TT; Kung YH; Hong MC
    Retina; 2011 Nov; 31(10):2071-7. PubMed ID: 21817964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
    Hesse L; Schmidt J; Kroll P
    Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):273-7. PubMed ID: 10208258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Macular translocation with 360 retinectomy for submacular hemorrhage in age related macular degeneration].
    Stopa M; Kociecki J
    Klin Oczna; 2009; 111(1-3):50-5. PubMed ID: 19517847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The intravitreal application of the tissue plasminogen activator in the treatment of submacular hemorrhage--a case report].
    Fric E; Sín M; Rehák M; Chrapek O; Simicák J; Fehák J
    Cesk Slov Oftalmol; 2008 Nov; 64(6):237-40. PubMed ID: 19110965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
    Chen CY; Hooper C; Chiu D; Chamberlain M; Karia N; Heriot WJ
    Retina; 2007 Mar; 27(3):321-8. PubMed ID: 17460587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness.
    Mitchell J; Wolffsohn J; Woodcock A; Anderson SJ; Ffytche T; Rubinstein M; Amoaku W; Bradley C
    Am J Ophthalmol; 2008 Sep; 146(3):447-454. PubMed ID: 18547542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemorrhagic age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, gas tamponade, and upright positioning.
    Kapran Z; Ozkaya A; Uyar OM
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(5):471-6. PubMed ID: 24044710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subretinal hematoma in age-related macular degeneration: treatment with intravitreal injection of tPA and gas].
    Leguay J; Gastaud P
    J Fr Ophtalmol; 2000 Oct; 23(8):797-801. PubMed ID: 11033502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD.
    Avila MP; Farah ME; Santos A; Kapran Z; Duprat JP; Woodward BW; Nau J
    Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.